HIGHLIGHTS
- who: Li Li from the University of Erlangen Nuremberg, Germany have published the article: Potential 18F-RGD PET/CT and DCE-MRI Imaging-Based Biomarkers for Postoperative Survival Prediction Among Patients With Newly Diagnosed Glioblastoma Treated With Bevacizumab and Chemoradiotherapy, in the Journal: (JOURNAL) of November/20,/2013
- what: This study shows that 18F-RGD PET/CT and DCE-MRI examination maybe useful for identifying glioblastoma patients likely to benefit from treatment with the combination of bevacizumab and CCRT, with a greater decrease in SUVmean predicting better PFS as well as a smaller decrease in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.